BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Science in Boston - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://scienceinboston.com
X-WR-CALDESC:Events for Science in Boston
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Vancouver
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20190310T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20191103T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20200308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20201101T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20210314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20211107T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20190310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20191103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20200308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20201101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200608T080000
DTEND;TZID=America/Vancouver:20200612T170000
DTSTAMP:20260417T032523
CREATED:20200415T154914Z
LAST-MODIFIED:20200415T154914Z
UID:8688-1591603200-1591981200@scienceinboston.com
SUMMARY:BIO Digital
DESCRIPTION:When collaboration is more vital than ever\, you can still rely on BIO to bring the industry together.\n\n\nFor 2020\, the BIO International Convention will transition to a new\, virtual event format\, BIO Digital. This virtual gathering of the global biotech industry provides access to key partners via BIO One-on-One Partnering\, educational resources to help drive your business\, and the insights you need to continue critical research and development. \nWe may not be able to gather in person\, but nothing stops innovation.
URL:https://scienceinboston.com/event/bio-digital/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200608T080000
DTEND;TZID=America/Vancouver:20200612T170000
DTSTAMP:20260417T032523
CREATED:20200415T154914Z
LAST-MODIFIED:20200415T154914Z
UID:27450-1591603200-1591981200@scienceinboston.com
SUMMARY:BIO Digital
DESCRIPTION:When collaboration is more vital than ever\, you can still rely on BIO to bring the industry together.\n\n\nFor 2020\, the BIO International Convention will transition to a new\, virtual event format\, BIO Digital. This virtual gathering of the global biotech industry provides access to key partners via BIO One-on-One Partnering\, educational resources to help drive your business\, and the insights you need to continue critical research and development. \nWe may not be able to gather in person\, but nothing stops innovation.
URL:https://scienceinboston.com/event/bio-digital-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200609T110000
DTEND;TZID=America/Vancouver:20200609T113000
DTSTAMP:20260417T032523
CREATED:20200522T175814Z
LAST-MODIFIED:20200522T175814Z
UID:9144-1591700400-1591702200@scienceinboston.com
SUMMARY:MassBio Town Hall W/ Special Guest Congresswoman Katherine Clark – Spotlight On The Federal Government’s Response To COVID
DESCRIPTION:MassBio’s President & CEO\, Bob Coughlin\, will host a weekly virtual Town Hall for members\, taking place every Tuesday at 11am. This will be an opportunity for our members to ask questions\, hear what MassBio is up to\, and learn more about the state of the industry amidst the COVID-19 pandemic. \nFor this Town Hall\, Bob will be joined by special guest Congresswoman Katherine Clark (MA-05) who will share insights on the federal government’s work around COVID-19 and how the life sciences industry can continue to support these efforts. \nWebinar link will be emailed to participants the day before – you can also access it from the “Live Stream” tab below. This event is for members-only. \nNOTE: MassBio makes every effort to accommodate our entire community at each of our events. Please let us know at least 3 days in advance of the event if you require special accommodations\, such as captioning.
URL:https://scienceinboston.com/event/massbio-town-hall-w-special-guest-congresswoman-katherine-clark-spotlight-on-the-federal-governments-response-to-covid/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200609T110000
DTEND;TZID=America/Vancouver:20200609T113000
DTSTAMP:20260417T032523
CREATED:20200522T175814Z
LAST-MODIFIED:20200522T175814Z
UID:27492-1591700400-1591702200@scienceinboston.com
SUMMARY:MassBio Town Hall W/ Special Guest Congresswoman Katherine Clark – Spotlight On The Federal Government’s Response To COVID
DESCRIPTION:MassBio’s President & CEO\, Bob Coughlin\, will host a weekly virtual Town Hall for members\, taking place every Tuesday at 11am. This will be an opportunity for our members to ask questions\, hear what MassBio is up to\, and learn more about the state of the industry amidst the COVID-19 pandemic. \nFor this Town Hall\, Bob will be joined by special guest Congresswoman Katherine Clark (MA-05) who will share insights on the federal government’s work around COVID-19 and how the life sciences industry can continue to support these efforts. \nWebinar link will be emailed to participants the day before – you can also access it from the “Live Stream” tab below. This event is for members-only. \nNOTE: MassBio makes every effort to accommodate our entire community at each of our events. Please let us know at least 3 days in advance of the event if you require special accommodations\, such as captioning.
URL:https://scienceinboston.com/event/massbio-town-hall-w-special-guest-congresswoman-katherine-clark-spotlight-on-the-federal-governments-response-to-covid-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200609T130000
DTEND;TZID=America/Vancouver:20200609T140000
DTSTAMP:20260417T032523
CREATED:20200527T172636Z
LAST-MODIFIED:20200527T172738Z
UID:9204-1591707600-1591711200@scienceinboston.com
SUMMARY:STAT+ Conversations: A Conversation with Merck on Developing COVID-19 Vaccines and Treatments
DESCRIPTION:STAT+ Conversations: A weekly broadcast where you’ll hear from STAT reporters\, and leaders in health and medicine\nSpeakers: \n\nJulie Gerberding\, executive vice president and chief patient officer\, communications\, global policy\, and population health\, Merck\nHelen Branswell\, senior writer\, infectious disease\, STAT
URL:https://scienceinboston.com/event/stat-conversations-a-conversation-with-merck-on-developing-covid-19-vaccines-and-treatments/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200609T130000
DTEND;TZID=America/Vancouver:20200609T140000
DTSTAMP:20260417T032523
CREATED:20200527T172636Z
LAST-MODIFIED:20200527T172636Z
UID:27497-1591707600-1591711200@scienceinboston.com
SUMMARY:STAT+ Conversations: A Conversation with Merck on Developing COVID-19 Vaccines and Treatments
DESCRIPTION:STAT+ Conversations: A weekly broadcast where you’ll hear from STAT reporters\, and leaders in health and medicine\nSpeakers: \n\nJulie Gerberding\, executive vice president and chief patient officer\, communications\, global policy\, and population health\, Merck\nHelen Branswell\, senior writer\, infectious disease\, STAT
URL:https://scienceinboston.com/event/stat-conversations-a-conversation-with-merck-on-developing-covid-19-vaccines-and-treatments-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200611T120000
DTEND;TZID=America/Vancouver:20200611T130000
DTSTAMP:20260417T032523
CREATED:20200527T204807Z
LAST-MODIFIED:20200527T204807Z
UID:9231-1591876800-1591880400@scienceinboston.com
SUMMARY:Harvard Microbial Sciences Initiative Summer Seminar
DESCRIPTION:We are pleased to announce an MSI virtual seminar series! On the second Thursday of each month this summer\, we’re bringing you a seminar full of interesting microbiology and the interesting microbiologist who makes it happen.\nMark your calendar for the first in the series: on Thursday\, June 11\, 2020 @ 12pm EST\, we’ll hear from Dr. Ronald Oremland. The seminars will be free and open to all\, no registration or sign up required. Faculty\, staff\, postdocs\, graduate students\, undergraduates\, and microbe enthusiasts of any variety are encouraged to attend. The talk will be streamed live on our YouTube channel\, so if you attended the 2020 symposium\, you already know what to do! And if you can’t make it to the live event\, no need to worry – the talk will be recorded and available on the MSI YouTube channel afterward.
URL:https://scienceinboston.com/event/harvard-microbial-sciences-initiative-summer-seminar/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinboston.com/wp-content/uploads/sites/6/2020/05/MSI-virtual-seminar-series.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200611T120000
DTEND;TZID=America/Vancouver:20200611T130000
DTSTAMP:20260417T032523
CREATED:20200527T204807Z
LAST-MODIFIED:20200527T204807Z
UID:27498-1591876800-1591880400@scienceinboston.com
SUMMARY:Harvard Microbial Sciences Initiative Summer Seminar
DESCRIPTION:We are pleased to announce an MSI virtual seminar series! On the second Thursday of each month this summer\, we’re bringing you a seminar full of interesting microbiology and the interesting microbiologist who makes it happen.\nMark your calendar for the first in the series: on Thursday\, June 11\, 2020 @ 12pm EST\, we’ll hear from Dr. Ronald Oremland. The seminars will be free and open to all\, no registration or sign up required. Faculty\, staff\, postdocs\, graduate students\, undergraduates\, and microbe enthusiasts of any variety are encouraged to attend. The talk will be streamed live on our YouTube channel\, so if you attended the 2020 symposium\, you already know what to do! And if you can’t make it to the live event\, no need to worry – the talk will be recorded and available on the MSI YouTube channel afterward.
URL:https://scienceinboston.com/event/harvard-microbial-sciences-initiative-summer-seminar-2/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinboston.com/wp-content/uploads/sites/6/2020/05/MSI-virtual-seminar-series.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200611T120000
DTEND;TZID=America/Vancouver:20200611T130000
DTSTAMP:20260417T032523
CREATED:20200602T204813Z
LAST-MODIFIED:20200602T204813Z
UID:9310-1591876800-1591880400@scienceinboston.com
SUMMARY:Building Better COVID-19 Tools Together: Using Scalable NGS to Accelerate Science
DESCRIPTION:With the numerous plasmids being shared by the research community for COVID-19 research\, Addgene acted fast to get these reagents available to scientists\, through QC and distribution. Learn about their QC workflows using NGS in an upcoming webinar with co-hosted by Addgene and seqWell. \nJune 11\, 2020\n12pm Eastern/9am Pacific \nSpeakers:\nJoseph Mellor\, Ph.D.\, CEO\, seqWell\nJoanne Kamens\, Ph.D.\, Executive Director\, Addgene \nSign up to join us: https://sambasci.com/seqwell-webinar-building-better-covid-19-tools-together/ \n—— \nAddgene is a nonprofit plasmid repository whose mission is to accelerate research and discovery by improving access to useful research materials and information. Addgene facilitates the sharing of high-quality scientific materials\, research reproducibility\, and open science by archiving and distributing DNA-based research reagents and associated data to scientists worldwide.
URL:https://scienceinboston.com/event/building-better-covid-19-tools-together-using-scalable-ngs-to-accelerate-science/
ATTACH;FMTTYPE=image/jpeg:https://scienceinboston.com/wp-content/uploads/sites/6/2020/06/seqwell-webinar-social-01.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200611T120000
DTEND;TZID=America/Vancouver:20200611T130000
DTSTAMP:20260417T032523
CREATED:20200602T204813Z
LAST-MODIFIED:20200602T204813Z
UID:27504-1591876800-1591880400@scienceinboston.com
SUMMARY:Building Better COVID-19 Tools Together: Using Scalable NGS to Accelerate Science
DESCRIPTION:With the numerous plasmids being shared by the research community for COVID-19 research\, Addgene acted fast to get these reagents available to scientists\, through QC and distribution. Learn about their QC workflows using NGS in an upcoming webinar with co-hosted by Addgene and seqWell. \nJune 11\, 2020\n12pm Eastern/9am Pacific \nSpeakers:\nJoseph Mellor\, Ph.D.\, CEO\, seqWell\nJoanne Kamens\, Ph.D.\, Executive Director\, Addgene \nSign up to join us: https://sambasci.com/seqwell-webinar-building-better-covid-19-tools-together/ \n—— \nAddgene is a nonprofit plasmid repository whose mission is to accelerate research and discovery by improving access to useful research materials and information. Addgene facilitates the sharing of high-quality scientific materials\, research reproducibility\, and open science by archiving and distributing DNA-based research reagents and associated data to scientists worldwide.
URL:https://scienceinboston.com/event/building-better-covid-19-tools-together-using-scalable-ngs-to-accelerate-science-2/
ATTACH;FMTTYPE=image/jpeg:https://scienceinboston.com/wp-content/uploads/sites/6/2020/06/seqwell-webinar-social-01.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200612T160000
DTEND;TZID=America/Vancouver:20200612T170000
DTSTAMP:20260417T032523
CREATED:20200610T210441Z
LAST-MODIFIED:20200610T210441Z
UID:9413-1591977600-1591981200@scienceinboston.com
SUMMARY:MGH Martinos Science on Tap
DESCRIPTION:Zoom link: https://zoom.us/j/658603416 \nGrab your own snacks and drinks and join the talk at 4:00pm. \nShare your “BYOB Science on Tap” selfies using @MGHMartinos or #MGHMartinos and let’s celebrate our Fridays together! \n  \nIf you’d like to tell the Martinos Community about your work in 10 mins\, email: \nMaaike van den Boomen
URL:https://scienceinboston.com/event/mgh-martinos-science-on-tap/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200612T160000
DTEND;TZID=America/Vancouver:20200612T170000
DTSTAMP:20260417T032523
CREATED:20200610T210441Z
LAST-MODIFIED:20200610T210441Z
UID:27507-1591977600-1591981200@scienceinboston.com
SUMMARY:MGH Martinos Science on Tap
DESCRIPTION:Zoom link: https://zoom.us/j/658603416 \nGrab your own snacks and drinks and join the talk at 4:00pm. \nShare your “BYOB Science on Tap” selfies using @MGHMartinos or #MGHMartinos and let’s celebrate our Fridays together! \n  \nIf you’d like to tell the Martinos Community about your work in 10 mins\, email: \nMaaike van den Boomen
URL:https://scienceinboston.com/event/mgh-martinos-science-on-tap-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200615T193000
DTEND;TZID=America/Vancouver:20200615T213000
DTSTAMP:20260417T032523
CREATED:20200610T210755Z
LAST-MODIFIED:20200610T210755Z
UID:9416-1592249400-1592256600@scienceinboston.com
SUMMARY:Molecular Biology Journal Club
DESCRIPTION:The Plan:\nMolecular biology journal club covering papers from all realms of life. \nSchedule:\n7:30pm – 9:00pm \nUseful apparatus:\nA printed copy of the paper or a laptop. \nImportant to know:\nThe paper will be disseminated via our Discord in the #molecular-biology channel. \nDiscord: https://discord.gg/BRNguhy
URL:https://scienceinboston.com/event/molecular-biology-journal-club/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200615T193000
DTEND;TZID=America/Vancouver:20200615T213000
DTSTAMP:20260417T032523
CREATED:20200610T210755Z
LAST-MODIFIED:20200610T210755Z
UID:27508-1592249400-1592256600@scienceinboston.com
SUMMARY:Molecular Biology Journal Club
DESCRIPTION:The Plan:\nMolecular biology journal club covering papers from all realms of life. \nSchedule:\n7:30pm – 9:00pm \nUseful apparatus:\nA printed copy of the paper or a laptop. \nImportant to know:\nThe paper will be disseminated via our Discord in the #molecular-biology channel. \nDiscord: https://discord.gg/BRNguhy
URL:https://scienceinboston.com/event/molecular-biology-journal-club-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200616T090000
DTEND;TZID=America/Vancouver:20200616T100000
DTSTAMP:20260417T032523
CREATED:20200527T205307Z
LAST-MODIFIED:20200527T205327Z
UID:9238-1592298000-1592301600@scienceinboston.com
SUMMARY:BU Center for Regenerative Medicine Seminar: PI Showcase featuring Jason Rock
DESCRIPTION:The Center for Regenerative Medicine Seminar Series features invited speakers presenting topics related to stem cell biology\, developmental biology\, gene therapy\, tissue injury and repair\, or regenerative medicine. All are welcome to attend and no RSVP is needed. If you would like be added to the CReM Seminar Series e-mail list\, please direct your request to Gustavo Mostoslavsky. \nPlease contact the Seminar Series organizers\, Dr. Darrell Kotton (dkotton@bu.edu) or Dr. Gustavo Mostoslavsky (gmostosl@bu.edu) with any other inquiries. \nJason Rock\, PhD\nAssociate Professor\, Center for Regenerative Medicine (CReM) BU-BMC \nPI Showcase
URL:https://scienceinboston.com/event/bu-center-for-regenerative-medicine-seminar-pi-showcase-featuring-jason-rock/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200616T090000
DTEND;TZID=America/Vancouver:20200616T100000
DTSTAMP:20260417T032523
CREATED:20200527T205307Z
LAST-MODIFIED:20200527T205307Z
UID:27500-1592298000-1592301600@scienceinboston.com
SUMMARY:BU Center for Regenerative Medicine Seminar: PI Showcase featuring Jason Rock
DESCRIPTION:The Center for Regenerative Medicine Seminar Series features invited speakers presenting topics related to stem cell biology\, developmental biology\, gene therapy\, tissue injury and repair\, or regenerative medicine. All are welcome to attend and no RSVP is needed. If you would like be added to the CReM Seminar Series e-mail list\, please direct your request to Gustavo Mostoslavsky. \nPlease contact the Seminar Series organizers\, Dr. Darrell Kotton (dkotton@bu.edu) or Dr. Gustavo Mostoslavsky (gmostosl@bu.edu) with any other inquiries. \nJason Rock\, PhD\nAssociate Professor\, Center for Regenerative Medicine (CReM) BU-BMC \nPI Showcase
URL:https://scienceinboston.com/event/bu-center-for-regenerative-medicine-seminar-pi-showcase-featuring-jason-rock-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200617T100000
DTEND;TZID=America/Vancouver:20200617T110000
DTSTAMP:20260417T032523
CREATED:20200611T170928Z
LAST-MODIFIED:20200611T170928Z
UID:9447-1592388000-1592391600@scienceinboston.com
SUMMARY:RNA Collaborative Seminar Series
DESCRIPTION:The RNA Collaborative seminar series goal is to cross promote RNA research and strengthen and connect the RNA scientific community. These seminars are organized by the RNA Centers of the following institutions: MD Anderson Center for RNA Interference and Non-Coding RNAs; Harvard Medical School Initiative for RNA Medicine; NCI RNA Biology Initiative; RiboClub Sherbrooke\, Québec; The RNA Institute\, University At Albany; UMass Medical School\, RNA Therapeutics Institute; University of Michigan Center for RNA Biomedicine;University of Rochester Center for RNA Biology; Yale Center for RNA Science and Medicine. Register here to join our June 17\, 2020 seminar at 4pm. If you are unable to make this time\, we will email you a link to watch the recorded seminar on demand.
URL:https://scienceinboston.com/event/rna-collaborative-seminar-series/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinboston.com/wp-content/uploads/sites/6/2020/06/RNA-Collaborative-Seminar-Series.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200617T100000
DTEND;TZID=America/Vancouver:20200617T110000
DTSTAMP:20260417T032523
CREATED:20200611T170928Z
LAST-MODIFIED:20200611T170928Z
UID:27512-1592388000-1592391600@scienceinboston.com
SUMMARY:RNA Collaborative Seminar Series
DESCRIPTION:The RNA Collaborative seminar series goal is to cross promote RNA research and strengthen and connect the RNA scientific community. These seminars are organized by the RNA Centers of the following institutions: MD Anderson Center for RNA Interference and Non-Coding RNAs; Harvard Medical School Initiative for RNA Medicine; NCI RNA Biology Initiative; RiboClub Sherbrooke\, Québec; The RNA Institute\, University At Albany; UMass Medical School\, RNA Therapeutics Institute; University of Michigan Center for RNA Biomedicine;University of Rochester Center for RNA Biology; Yale Center for RNA Science and Medicine. Register here to join our June 17\, 2020 seminar at 4pm. If you are unable to make this time\, we will email you a link to watch the recorded seminar on demand.
URL:https://scienceinboston.com/event/rna-collaborative-seminar-series-3/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinboston.com/wp-content/uploads/sites/6/2020/06/RNA-Collaborative-Seminar-Series.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200617T120000
DTEND;TZID=America/Vancouver:20200617T130000
DTSTAMP:20260417T032523
CREATED:20200615T181741Z
LAST-MODIFIED:20200615T181741Z
UID:9464-1592395200-1592398800@scienceinboston.com
SUMMARY:New Horizons in Therapeutic Antibody Discovery: Challenges and Opportunities for Improvement
DESCRIPTION:Biologics are the fastest growing class of therapeutics in the biopharmaceutical industry. A key driver for this growth is success with anticancer immunotherapeutics such as checkpoint modulation\, adoptive cell therapy\, and bispecific T-cell engagers. While these approaches use different tactics to attack tumors\, they often employ monoclonal antibodies to target specific antigens. In this highly competitive field\, it is crucial to identify candidate antibodies with superior target reactivity. The first step in this process involves screening antibody libraries to identify binders. This can be achieved by using either display technologies or animal immunization. Once antibodies have been identified and slated for production\, they must be further characterized and tested for performance-related characteristics before moving into preclinical testing. \nDuring the webinar\, the speakers will: \n\nProvide an overview of the therapeutic antibody discovery landscape\nDiscuss the successes and limitations of current antibody discovery technologies\nOffer case studies of antibody screening and characterization\nAnswer viewer questions during the live broadcast.
URL:https://scienceinboston.com/event/new-horizons-in-therapeutic-antibody-discovery-challenges-and-opportunities-for-improvement/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200617T120000
DTEND;TZID=America/Vancouver:20200617T130000
DTSTAMP:20260417T032523
CREATED:20200615T181741Z
LAST-MODIFIED:20200615T181741Z
UID:27513-1592395200-1592398800@scienceinboston.com
SUMMARY:New Horizons in Therapeutic Antibody Discovery: Challenges and Opportunities for Improvement
DESCRIPTION:Biologics are the fastest growing class of therapeutics in the biopharmaceutical industry. A key driver for this growth is success with anticancer immunotherapeutics such as checkpoint modulation\, adoptive cell therapy\, and bispecific T-cell engagers. While these approaches use different tactics to attack tumors\, they often employ monoclonal antibodies to target specific antigens. In this highly competitive field\, it is crucial to identify candidate antibodies with superior target reactivity. The first step in this process involves screening antibody libraries to identify binders. This can be achieved by using either display technologies or animal immunization. Once antibodies have been identified and slated for production\, they must be further characterized and tested for performance-related characteristics before moving into preclinical testing. \nDuring the webinar\, the speakers will: \n\nProvide an overview of the therapeutic antibody discovery landscape\nDiscuss the successes and limitations of current antibody discovery technologies\nOffer case studies of antibody screening and characterization\nAnswer viewer questions during the live broadcast.
URL:https://scienceinboston.com/event/new-horizons-in-therapeutic-antibody-discovery-challenges-and-opportunities-for-improvement-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200618T080000
DTEND;TZID=America/Vancouver:20200618T090000
DTSTAMP:20260417T032523
CREATED:20200522T175857Z
LAST-MODIFIED:20200522T175857Z
UID:9146-1592467200-1592470800@scienceinboston.com
SUMMARY:From Brainstorm To Boardroom: When Is The Right Time For A Faculty To Form A Startup?
DESCRIPTION:Much of the innovation in Massachusetts stems from academic and medical centers contributing to the startup ecosystem\, attracting talent and capital. The key to this development is for faculty to commercialize their findings\, but the path to business can be daunting when considering conflict of interest\, project management\, and ultimately the decision as to when is the best time to form a startup. The goal of this forum will be to discuss these issues with academic entrepreneurs at different levels of a startup to provide insight into the decisions and resources necessary for a successful startup.\nKey topics for discussion: \n– What are the different paths for commercialization? (i.e. founder\, co-founder\, consultant\, etc.)\n– How to deal with conflict of interest and IP at these different levels\n– Resources for deciding when is the right time (i.e. tech transfer office\, incubators\, etc.)\n– How to manage your time between the lab\, startup\, and family\n– Finding the right people to work with\n– Return of Investment for academics for startups \nBrought to you be the Academic Industry Relations working group.
URL:https://scienceinboston.com/event/from-brainstorm-to-boardroom-when-is-the-right-time-for-a-faculty-to-form-a-startup/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200618T080000
DTEND;TZID=America/Vancouver:20200618T090000
DTSTAMP:20260417T032523
CREATED:20200522T175857Z
LAST-MODIFIED:20200522T175857Z
UID:27493-1592467200-1592470800@scienceinboston.com
SUMMARY:From Brainstorm To Boardroom: When Is The Right Time For A Faculty To Form A Startup?
DESCRIPTION:Much of the innovation in Massachusetts stems from academic and medical centers contributing to the startup ecosystem\, attracting talent and capital. The key to this development is for faculty to commercialize their findings\, but the path to business can be daunting when considering conflict of interest\, project management\, and ultimately the decision as to when is the best time to form a startup. The goal of this forum will be to discuss these issues with academic entrepreneurs at different levels of a startup to provide insight into the decisions and resources necessary for a successful startup.\nKey topics for discussion: \n– What are the different paths for commercialization? (i.e. founder\, co-founder\, consultant\, etc.)\n– How to deal with conflict of interest and IP at these different levels\n– Resources for deciding when is the right time (i.e. tech transfer office\, incubators\, etc.)\n– How to manage your time between the lab\, startup\, and family\n– Finding the right people to work with\n– Return of Investment for academics for startups \nBrought to you be the Academic Industry Relations working group.
URL:https://scienceinboston.com/event/from-brainstorm-to-boardroom-when-is-the-right-time-for-a-faculty-to-form-a-startup-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200622T140000
DTEND;TZID=America/Vancouver:20200622T150000
DTSTAMP:20260417T032523
CREATED:20200610T211932Z
LAST-MODIFIED:20200610T211932Z
UID:9423-1592834400-1592838000@scienceinboston.com
SUMMARY:Helen Gurley Brown Presidential Summit on Women and Science
DESCRIPTION:Join us virtually to hear from prominent female leaders in the science community as we celebrate and support women in cancer research and medicine. Panel discussion features: \nLaurie H. Glimcher\, MD (Moderator)\nPresident & CEO\, Dana-Farber Cancer Institute; Principal Investigator and Director\, Dana-Farber/Harvard Cancer Center; Richard and Susan Smith Professor of Medicine\, Harvard Medical School \nSangeeta N. Bhatia\, MD\, PhD\nJohn J. and Dorothy Wilson Professor of Engineering\, Massachusetts Institute of Technology \nMichele Cleary\, PhD\nChief Executive Officer\, The Mark Foundation for Cancer Research \nMartine Rothblatt\, PhD\nChairman & Chief Executive Officer\, United Therapeutics \nRSVP to Madeline Hoadley at madeline_hoadley@dfci.harvard.edu. Questions for panelists can be submitted with your RSVP.
URL:https://scienceinboston.com/event/helen-gurley-brown-presidential-summit-on-women-and-science/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200622T140000
DTEND;TZID=America/Vancouver:20200622T150000
DTSTAMP:20260417T032523
CREATED:20200610T211932Z
LAST-MODIFIED:20200610T211932Z
UID:27511-1592834400-1592838000@scienceinboston.com
SUMMARY:Helen Gurley Brown Presidential Summit on Women and Science
DESCRIPTION:Join us virtually to hear from prominent female leaders in the science community as we celebrate and support women in cancer research and medicine. Panel discussion features: \nLaurie H. Glimcher\, MD (Moderator)\nPresident & CEO\, Dana-Farber Cancer Institute; Principal Investigator and Director\, Dana-Farber/Harvard Cancer Center; Richard and Susan Smith Professor of Medicine\, Harvard Medical School \nSangeeta N. Bhatia\, MD\, PhD\nJohn J. and Dorothy Wilson Professor of Engineering\, Massachusetts Institute of Technology \nMichele Cleary\, PhD\nChief Executive Officer\, The Mark Foundation for Cancer Research \nMartine Rothblatt\, PhD\nChairman & Chief Executive Officer\, United Therapeutics \nRSVP to Madeline Hoadley at madeline_hoadley@dfci.harvard.edu. Questions for panelists can be submitted with your RSVP.
URL:https://scienceinboston.com/event/helen-gurley-brown-presidential-summit-on-women-and-science-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200622T193000
DTEND;TZID=America/Vancouver:20200622T213000
DTSTAMP:20260417T032523
CREATED:20200610T210941Z
LAST-MODIFIED:20200610T210941Z
UID:9419-1592854200-1592861400@scienceinboston.com
SUMMARY:Synthetic Biology Journal Club
DESCRIPTION:Synthetic Biology Journal Club with interests ranging from biocomputation to terraforming. Passion for biology required. \nMore details:\nPapers will be mostly recent publications in an effort to keep up with the field. Having read the material prior to the meetup is encouraged but not necessary. \nSchedule:\n7:30pm – 9:00pm\, every other week. \nUseful apparatus:\nA printed copy of the paper or a laptop (preferably both). \nImportant to know:\nPapers will be disseminated through our Discord channel: #synthetic-biology. \nDiscord: https://discord.gg/BRNguhy
URL:https://scienceinboston.com/event/synthetic-biology-journal-club/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200622T193000
DTEND;TZID=America/Vancouver:20200622T213000
DTSTAMP:20260417T032523
CREATED:20200610T210941Z
LAST-MODIFIED:20200610T210941Z
UID:27509-1592854200-1592861400@scienceinboston.com
SUMMARY:Synthetic Biology Journal Club
DESCRIPTION:Synthetic Biology Journal Club with interests ranging from biocomputation to terraforming. Passion for biology required. \nMore details:\nPapers will be mostly recent publications in an effort to keep up with the field. Having read the material prior to the meetup is encouraged but not necessary. \nSchedule:\n7:30pm – 9:00pm\, every other week. \nUseful apparatus:\nA printed copy of the paper or a laptop (preferably both). \nImportant to know:\nPapers will be disseminated through our Discord channel: #synthetic-biology. \nDiscord: https://discord.gg/BRNguhy
URL:https://scienceinboston.com/event/synthetic-biology-journal-club-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200623T080000
DTEND;TZID=America/Vancouver:20200627T170000
DTSTAMP:20260417T032523
CREATED:20200610T210153Z
LAST-MODIFIED:20200610T210153Z
UID:9410-1592899200-1593277200@scienceinboston.com
SUMMARY:ISSCR 2020 Virtual Annual Meeting
DESCRIPTION:The ISSCR Annual Meeting gathers the world’s leading scientists\, clinicians\, business leaders\, ethicists\, and educators from more than 65 countries. Together\, we represent the full spectrum of stem cell science and regenerative medicine. Discovery\, new business\, careers\, advocacy\, and relationships start here.
URL:https://scienceinboston.com/event/isscr-2020-virtual-annual-meeting/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200623T080000
DTEND;TZID=America/Vancouver:20200627T170000
DTSTAMP:20260417T032523
CREATED:20200610T210153Z
LAST-MODIFIED:20200610T210153Z
UID:27506-1592899200-1593277200@scienceinboston.com
SUMMARY:ISSCR 2020 Virtual Annual Meeting
DESCRIPTION:The ISSCR Annual Meeting gathers the world’s leading scientists\, clinicians\, business leaders\, ethicists\, and educators from more than 65 countries. Together\, we represent the full spectrum of stem cell science and regenerative medicine. Discovery\, new business\, careers\, advocacy\, and relationships start here.
URL:https://scienceinboston.com/event/isscr-2020-virtual-annual-meeting-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200623T133000
DTEND;TZID=America/New_York:20200623T141500
DTSTAMP:20260417T032523
CREATED:20200619T175340Z
LAST-MODIFIED:20200619T175340Z
UID:9558-1592919000-1592921700@scienceinboston.com
SUMMARY:Innovation and Biotech in the Time of COVID-19: Tech Transfer
DESCRIPTION:This webinar series will feature biotech industry leaders\, experts\, and entrepreneurs discussing COVID-19 and its impact on innovation. \nIn our ninth panel\, we’ll discuss the effect a pandemic has had on Tech Transfer offices. Hear from experts in the field – what will the future hold? \nSpeakers include: \nMichal Preminger\, PhD\, MBA\, Head\, Johnson & Johnson Innovation\, East North America \nMichal is Head of Johnson & Johnson Innovation\, East North America\, located at the Innovation Centre in Boston. In this role she leads the Innovation Center team to build\, advance\, and manage the External R&D portfolio of co-investments spanning across pharmaceutical\, consumer health and medical devices.\nUntil recently\, Michal served as the Executive Director of Harvard University’s Office of Technology Development (OTD) Harvard Medical School site\, where she was responsible for development and commercialization of technologies emerging from research at HMS laboratories and for the strategy and execution of all industry collaborations. She negotiated agreements with major biopharma\, life sciences\, food and cosmetics companies to advance the translation of discoveries into products and create a revenue-generating product pipeline\, and worked with scientific founders and investors to create new startup companies.\nPrior to joining Harvard University’s OTD in 2005\, Michal held a number of business development and technology development positions at Compugen\, most recently as VP of Protein Therapeutics\, responsible for the business management of the company’s emerging drug discovery pipeline. Previously\, she worked in the technology industry in marketing and business development roles\, and co-founded a biotechnology startup.\nMichal serves on the Scientific Advisory Boards FutuRx Accelerator\, and was\, until recently\, a member of the SAB of Prize4Life and a Member of the Board of Directors of a number of companies\, including Compugen and Alma Lasers.\nShe holds a Ph.D. in Biological Sciences from the Weizmann Institute of Science\, an MBA from INSEAD\, Fontainebleau\, France\, and a BA in Medicine from Hadassah Medical School\, Hebrew University\, Jerusalem.\nMichael Fenn\, Ph.D.\, Director of Healthcare and Life Sciences\, Harvard Innovation Labs \nDr. Michael Fenn is tasked with advising and supporting all healthcare and life science ventures with a focus on supporting founders seeking to drive innovations in human health\, which include students\, research fellows\, and alumni. Michael also serves as a liaison within the Harvard-affiliated healthcare and research communities\, as well the surrounding Boston-area ecosystem.\nHe is particularly passionate about bridging the gap between the academic research and venture worlds\, having worked extensively in both. Michael has served as cofounder\, advisor\, and board member for over 25 startups\, as well as several incubators and economic development committees. His entrepreneurial efforts have resulted in significant early-stage capital\, creation of intellectual property\, technology transfer\, and navigation of regulatory pathways. Dr. Fenn received his Ph.D. in Biomedical Engineering\, M.S. in Materials Science and Engineering\, and B.S. in Chemistry/Biochemistry\, all from the University of Florida.\nAaron Schwartz\, Search & Evaluation Director\, Global Drug Discovery\, Novo Nordisk \nAaron has been a Director in Novo Nordisk’s Search & Evaluation team in Global Drug Discovery since 2016. In this capacity\, Aaron is responsible for the search an evaluation of new therapeutics and enabling technologies for protein\, peptide\, and antibody drugs. Prior to joining Novo Nordisk\, Aaron worked in the MIT Technology Licensing Office for 13.5 years. During this time\, he worked on license and sponsored research agreements with life sciences companies from startups to big biotech/pharma and everything in between. He also managed a portfolio of over 650 technologies. Before Aaron’s time at MIT\, he was a management consultant to big pharma and a startup. Aaron has an undergrad degree in biology from the University of Chicago and a Masters degree in biology from MIT.\nOur webinar will be hosted on YouTube Live. Registrants will receive the link in an email shortly before broadcast.
URL:https://scienceinboston.com/event/innovation-and-biotech-in-the-time-of-covid-19-tech-transfer/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinboston.com/wp-content/uploads/sites/6/2020/06/Innovation-and-Biotech-Tech-transfer.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200623T133000
DTEND;TZID=America/New_York:20200623T141500
DTSTAMP:20260417T032523
CREATED:20200619T175340Z
LAST-MODIFIED:20200619T175340Z
UID:27515-1592919000-1592921700@scienceinboston.com
SUMMARY:Innovation and Biotech in the Time of COVID-19: Tech Transfer
DESCRIPTION:This webinar series will feature biotech industry leaders\, experts\, and entrepreneurs discussing COVID-19 and its impact on innovation. \nIn our ninth panel\, we’ll discuss the effect a pandemic has had on Tech Transfer offices. Hear from experts in the field – what will the future hold? \nSpeakers include: \nMichal Preminger\, PhD\, MBA\, Head\, Johnson & Johnson Innovation\, East North America \nMichal is Head of Johnson & Johnson Innovation\, East North America\, located at the Innovation Centre in Boston. In this role she leads the Innovation Center team to build\, advance\, and manage the External R&D portfolio of co-investments spanning across pharmaceutical\, consumer health and medical devices.\nUntil recently\, Michal served as the Executive Director of Harvard University’s Office of Technology Development (OTD) Harvard Medical School site\, where she was responsible for development and commercialization of technologies emerging from research at HMS laboratories and for the strategy and execution of all industry collaborations. She negotiated agreements with major biopharma\, life sciences\, food and cosmetics companies to advance the translation of discoveries into products and create a revenue-generating product pipeline\, and worked with scientific founders and investors to create new startup companies.\nPrior to joining Harvard University’s OTD in 2005\, Michal held a number of business development and technology development positions at Compugen\, most recently as VP of Protein Therapeutics\, responsible for the business management of the company’s emerging drug discovery pipeline. Previously\, she worked in the technology industry in marketing and business development roles\, and co-founded a biotechnology startup.\nMichal serves on the Scientific Advisory Boards FutuRx Accelerator\, and was\, until recently\, a member of the SAB of Prize4Life and a Member of the Board of Directors of a number of companies\, including Compugen and Alma Lasers.\nShe holds a Ph.D. in Biological Sciences from the Weizmann Institute of Science\, an MBA from INSEAD\, Fontainebleau\, France\, and a BA in Medicine from Hadassah Medical School\, Hebrew University\, Jerusalem.\nMichael Fenn\, Ph.D.\, Director of Healthcare and Life Sciences\, Harvard Innovation Labs \nDr. Michael Fenn is tasked with advising and supporting all healthcare and life science ventures with a focus on supporting founders seeking to drive innovations in human health\, which include students\, research fellows\, and alumni. Michael also serves as a liaison within the Harvard-affiliated healthcare and research communities\, as well the surrounding Boston-area ecosystem.\nHe is particularly passionate about bridging the gap between the academic research and venture worlds\, having worked extensively in both. Michael has served as cofounder\, advisor\, and board member for over 25 startups\, as well as several incubators and economic development committees. His entrepreneurial efforts have resulted in significant early-stage capital\, creation of intellectual property\, technology transfer\, and navigation of regulatory pathways. Dr. Fenn received his Ph.D. in Biomedical Engineering\, M.S. in Materials Science and Engineering\, and B.S. in Chemistry/Biochemistry\, all from the University of Florida.\nAaron Schwartz\, Search & Evaluation Director\, Global Drug Discovery\, Novo Nordisk \nAaron has been a Director in Novo Nordisk’s Search & Evaluation team in Global Drug Discovery since 2016. In this capacity\, Aaron is responsible for the search an evaluation of new therapeutics and enabling technologies for protein\, peptide\, and antibody drugs. Prior to joining Novo Nordisk\, Aaron worked in the MIT Technology Licensing Office for 13.5 years. During this time\, he worked on license and sponsored research agreements with life sciences companies from startups to big biotech/pharma and everything in between. He also managed a portfolio of over 650 technologies. Before Aaron’s time at MIT\, he was a management consultant to big pharma and a startup. Aaron has an undergrad degree in biology from the University of Chicago and a Masters degree in biology from MIT.\nOur webinar will be hosted on YouTube Live. Registrants will receive the link in an email shortly before broadcast.
URL:https://scienceinboston.com/event/innovation-and-biotech-in-the-time-of-covid-19-tech-transfer-2/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinboston.com/wp-content/uploads/sites/6/2020/06/Innovation-and-Biotech-Tech-transfer.png
END:VEVENT
END:VCALENDAR